HTA42 Use of Health-Related Quality of Life (HRQoL) Outcomes/Patient-Reported Outcomes (PROs) in Rare Hematological Disease (RHD) Health Technology Assessment (HTA) Submissions
- Resource Type
- Abstract
- Source
- In
Value in Health December 2022 25(12) Supplement:S304-S304 - Subject
- Language
- ISSN
- 1098-3015